A new study finds an increase in transcription factor TOX2 in people with natural killer/T-cell lymphoma.

A new substance may treat staph infections in people with skin lymphoma. That's good news for patients and fighting antibiotic resistance.

A new shingles vaccine may work where others have failed for patients with lymphoma, researchers report.

When levels of the protein are low, the immune system is "unleashed," which can kickstart a rare form of lymphoma.